Jakob Passweg
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Brune M, Cogliatti S, Ossenkoppele G, Löwenberg B, Rudolf C, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A, Fehr M, Grobholz R, Stussi G, Lundberg P, Vela V, Heim D, Manz M, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol 2021; 100:1169-1179.
Mar 2, 2021Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Mar 2, 2021Ann Hematol 2021; 100:1169-1179
Brune Magdalena M, Cogliatti Sergio B., Ossenkoppele Gert J, Löwenberg Bob, Rudolf Christina Biaggi, Li Qiyu, Passweg Jakob, Mazzuchelli Luca, Medinger Michael, Tzankov Alexandar, Fehr Martin, Grobholz Rainer, Stussi Georg, Lundberg Pontus, Vela Visar, Heim Dominik, Manz Markus G, Haralambieva Eugenia, Pabst Thomas, Banz Yara, Bargetzi Mario, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
Ossenkoppele G, Porkka K, Cornelissen J, Kuball J, Fischer T, Legdeur M, Hoogendoorn M, Breems D, Moors I, van Lammeren-Venema D, Silzle T, Juliusson G, Meyer P, Floisand Y, Manz M, van Elssen C, Valk P, Cloos J, Passweg J, Huls G, Janssen J, Gjertsen B, Höglund M, Gregor M, Veelken H, van Marwijk Kooy M, Jongen-Lavrencic M, Tick L, Griskevicius L, Vellenga E, Spertini O, Biemond B, Gradowska P, Maertens J, Pabst T, Vekemans M, van der Velden W, Westerweel P, Gadisseur A, Klein S, Bargetzi M, van Esser J, de Weerdt O, Deeren D, Graux C, Michaux L, Beverloo B, Löwenberg B. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial. Blood Adv 2021; 5:1110-1121.
Jan 23, 2021Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
Jan 23, 2021Blood Adv 2021; 5:1110-1121
Ossenkoppele Gert J, Porkka Kimmo, Cornelissen Jan, Kuball Juergen, Fischer Thomas, Legdeur Marie-Cecile J C, Hoogendoorn Mels, Breems Dimitri A, Moors Ine, van Lammeren-Venema Daniëlle, Silzle Tobias, Juliusson Gunnar, Meyer Peter, Floisand Yngvar, Manz Markus G, van Elssen Catharina H M J, Valk Peter J M, Cloos Jacqueline, Passweg Jakob, Huls Gerwin, Janssen Jeroen J W M, Gjertsen Bjorn T, Höglund Martin, Gregor Michael, Veelken Hendrik, van Marwijk Kooy Marinus, Jongen-Lavrencic Mojca, Tick Lidwine W, Griskevicius Laimonas, Vellenga Edo, Spertini Olivier, Biemond Bart J, Gradowska Patrycja, Maertens Johan, Pabst Thomas, Vekemans Marie-Christiane, van der Velden Walter J F M, Westerweel Peter E, Gadisseur Alain, Klein Saskia K, Bargetzi Mario, van Esser Joost W J, de Weerdt Okke, Deeren Dries, Graux Carlos, Michaux Lucienne, Beverloo Berna, Löwenberg Bob
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Benz R, O'Meara Stern A, Cantoni N, Bargetzi M, Bianchi-Papina E, Rossi D, Passweg J, Lohri A, Berardi S, Feller A, Rauch D, Blum S, Mey U, Arn K, Andres M, Pabst T, Baumann M, Novak U, Hitz F, Hess U, Zenhaeusern R, Chalandon Y, Stussi G. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Adv 2020; 4:3699-3707.
Aug 11, 2020Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Aug 11, 2020Blood Adv 2020; 4:3699-3707
Benz Rudolf, O'Meara Stern Alix, Cantoni Nathan, Bargetzi Mario, Bianchi-Papina Elena, Rossi Davide, Passweg Jakob, Lohri Andreas, Berardi Simona, Feller Anita, Rauch Daniel, Blum Sabine, Mey Ulrich, Arn Kornelius, Andres Martin, Pabst Thomas, Baumann Michael, Novak Urban, Hitz Felicitas, Hess Urs, Zenhaeusern Reinhard, Chalandon Yves, Stussi Georg
Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison
Baumgartner A, Mueller B, Stanga Z, Hess U, Duchosal M, Pabst T, Wannesson L, Limonta A, Pichard C, Chalandon Y, Samaras P, Schanz U, Passweg J, Medinger M, Zueger N, Bargetzi A, Bargetzi M, Schuetz P. Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison. Nutrition 2016; 35:43-50.
Oct 15, 2016Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison
Oct 15, 2016Nutrition 2016; 35:43-50
Baumgartner Annic, Mueller Beat, Stanga Zeno, Hess Urs, Duchosal Michel A, Pabst Thomas, Wannesson Luciano, Limonta Alessandro, Pichard Claude, Chalandon Yves, Samaras Panagiotis, Schanz Urs, Passweg Jakob, Medinger Micheal, Zueger Noemi, Bargetzi Annika, Bargetzi Mario, Schuetz Philipp
Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.
Sigle J, Holbro A, Lehmann T, Infanti L, Gerull S, Stern M, Tichelli A, Passweg J, Buser A. Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage. Am J Clin Pathol 2015; 144:145-50.
Jul 1, 2015Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.
Jul 1, 2015Am J Clin Pathol 2015; 144:145-50
Sigle Joerg P, Holbro Andreas, Lehmann Thomas, Infanti Laura, Gerull Sabine, Stern Martin, Tichelli André, Passweg Jakob, Buser Andreas
Erythropoietin receptor mutation--a rush of blood to the head?
Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T. Erythropoietin receptor mutation--a rush of blood to the head?. Ann Hematol 2015; 94:1229-31.
Mar 14, 2015Erythropoietin receptor mutation--a rush of blood to the head?
Mar 14, 2015Ann Hematol 2015; 94:1229-31
Holbro Andreas, Skoda Radek C, Lundberg Pontus, Passweg Jakob, Buser Andreas, Lehmann Thomas
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda R. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123:2220-8.
Jan 29, 2014Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Jan 29, 2014Blood 2014; 123:2220-8
Lundberg Pontus, Karow Axel, Nienhold Ronny, Looser Renate, Hao-Shen Hui, Nissen Ina, Girsberger Sabine, Lehmann Thomas, Passweg Jakob, Stern Martin, Beisel Christian, Kralovics Robert, Skoda Radek C
Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
Bucher C, Lehmann T, Tichelli A, Tzankov A, Dirnhofer S, Passweg J, Rovó A. Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial. J Clin Pathol 2012; 66:24-8.
Oct 26, 2012Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.
Oct 26, 2012J Clin Pathol 2012; 66:24-8
Bucher Christoph, Lehmann Thomas, Tichelli André, Tzankov Alexander, Dirnhofer Stephan, Passweg Jakob, Rovó Alicia
A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.
Medinger M, Saller E, Harteveld C, Lehmann T, Graf L, Rovó A, Buser A, Passweg J, Tichelli A. A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency. Hematol Rep 2011; 3:e30.
Dec 6, 2011A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.
Dec 6, 2011Hematol Rep 2011; 3:e30
Medinger Michael, Saller Elisabeth, Harteveld Cornelis L, Lehmann Thomas, Graf Lukas, Rovó Alicia, Buser Andreas, Passweg Jakob, Tichelli André
Aplastic anemia and concomitant autoimmune diseases
Stalder M, Tichelli A, Meyer-Monard S, Buser A, Arber C, Stern M, Rischewski J, Passweg J, Silzle T, Heim D, Halter J, Rovó A, Gratwohl A. Aplastic anemia and concomitant autoimmune diseases. Ann Hematol 2009; 88:659-65.
Jan 13, 2009Aplastic anemia and concomitant autoimmune diseases
Jan 13, 2009Ann Hematol 2009; 88:659-65
Stalder Magnus P, Tichelli André, Meyer-Monard Sandrine, Buser Andreas, Arber Caroline, Stern Martin, Rischewski Johannes, Passweg Jakob, Silzle Tobias, Heim Dominik, Halter Jörg, Rovó Alicia, Gratwohl Alois
Significant progress in palliative treatment of non-small cell lung cancer in the past decade
Waechter F, Passweg J, Tamm M, Brutsche M, Herrmann R, Pless M. Significant progress in palliative treatment of non-small cell lung cancer in the past decade. Chest 2005; 127:738-47.
Mar 1, 2005Significant progress in palliative treatment of non-small cell lung cancer in the past decade
Mar 1, 2005Chest 2005; 127:738-47
Waechter Frank, Passweg Jakob, Tamm Michael, Brutsche Martin, Herrmann Richard, Pless Miklos
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Lugli A, Tichelli A, Von Juergensonn S, Mach-Pascual S, Borisch B, Tinguely M, Hawle H, Korte W, Hess U, Passweg J, Gratwohl A, Cogliatti S, Ebnoether M, Dirnhofer S. Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. Hum Pathol 2005; 36:91-100.
Jan 1, 2005Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia
Jan 1, 2005Hum Pathol 2005; 36:91-100
Lugli Alessandro, Tichelli André, Von Juergensonn Silke, Mach-Pascual Sara, Borisch Bettina, Tinguely Marianne, Hawle Hanne, Korte Wolfgang, Hess Urs, Passweg Jakob, Gratwohl Alois, Cogliatti Sergio B., Ebnoether Monika, Dirnhofer Stephan